文献速递中毒与环境急症重症综合管理与镇静镇痛

故意摄入阿维菌素类农药:一项回顾性多中心研究

Intentional avermectin pesticide ingestion: a retrospective multicenter study.
PubMed 文献 · Clin Toxicol (Phila) · 2022-08-02
一句话结论故意摄入阿维菌素类农药者中42%需ICU、31%发生严重结局,GCS<13分和呼吸困难/气促与严重结局独立相关。

该多中心回顾性研究纳入2012年1月至2020年5月六家教学医院急诊科收治的64例急性阿维菌素类农药摄入患者,其中60例摄入甲氨基阿维菌素、4例摄入阿维菌素,98%为自伤。最常见表现为嗜睡(47%,中位GCS 14分),其次为呼吸困难/气促(33%)和恶心/呕吐(22%);17例(27%)插管,4例出现需升压药的持续低血压,4例死亡,50例(78%)住院、27例(42%)需ICU,20例(31%)发生严重结局。多因素logistic回归显示GCS<13分(OR 68.1,95%CI 3.8-999)和呼吸困难/气促(OR 50.2,95%CI 3.0-849.9)与严重结局独立相关。

要点

  • 故意摄入阿维菌素类农药后31%发生严重结局(死亡、插管或需升压药的持续低血压),42%需ICU治疗。
  • GCS<13分与严重结局独立相关(OR 68.1,95%CI 3.8-999),呼吸困难/气促亦独立相关(OR 50.2,95%CI 3.0-849.9)。
  • 17例(27%)插管,4例出现需升压药的持续低血压;4例死亡中3例有DNR医嘱。
  • 5例确认或怀疑同时经溶剂暴露甲醇,需考虑合并中毒可能。
  • 最常见表现为嗜睡(47%,中位GCS 14分),其次为呼吸困难/气促(33%)和恶心/呕吐(22%)。

适用人群与场景

  • 2012年1月至2020年5月六家教学医院急诊科因急性阿维菌素类农药摄入就诊的患者。
  • 排除报告摄入其他任何农药、药物或物质的患者。
  • 64例中60例摄入甲氨基阿维菌素、4例摄入阿维菌素;98%为自伤,中位年龄72岁。

诊断标准与关键阈值

  • 严重结局定义:死亡、插管或需升压药治疗的持续低血压。
  • GCS评分<13分与严重结局独立相关(OR 68.1,95%CI 3.8-999)。
  • 存在呼吸困难/气促与严重结局独立相关(OR 50.2,95%CI 3.0-849.9)。

红旗征与不能漏的情况

  • GCS<13分:与严重结局独立相关(OR 68.1,95%CI 3.8-999)。
  • 呼吸困难/气促:与严重结局独立相关(OR 50.2,95%CI 3.0-849.9)。
  • 持续低血压需升压药治疗:4例发生,属于严重结局定义之一。
  • 呼吸衰竭:3例因DNR医嘱未插管,其中部分死亡。

研究设计与关键结果

  • 多中心回顾性研究,纳入64例(中位年龄72岁),60例摄入甲氨基阿维菌素、4例摄入阿维菌素,98%为自伤。
  • 最常见表现为嗜睡(47%,中位GCS 14分),其次为呼吸困难/气促(33%)、恶心/呕吐(22%);5例确认或怀疑同时暴露甲醇。
  • 17例(27%)插管;4例出现需升压药的持续低血压;50例(78%)住院,27例(42%)需ICU,4例死亡(其中3例有DNR医嘱)。
  • 按定义20例(31%)发生严重结局;多因素logistic回归显示GCS<13分(OR 68.1,95%CI 3.8-999)和呼吸困难/气促(OR 50.2,95%CI 3.0-849.9)与严重结局独立相关。

证据类型、等级与局限

  • 证据类型:多中心回顾性研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 故意摄入阿维菌素类农药的患者多数需住院治疗(78%),42%需ICU监护。
  • 急诊评估中GCS<13分或出现呼吸困难/气促提示严重结局风险高,应加强监护与气道准备。
  • 需注意溶剂中甲醇合并暴露的可能(5例确认或怀疑),并评估持续低血压需升压药治疗的风险。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

CONTEXT: Avermectin pesticides are widely used in agriculture, and are thought to have low toxicity in humans. However, information on their toxicity after accidental or deliberate ingestion is limited.

OBJECTIVE: The aim of this study was to evaluate the clinical manifestations of avermectin pesticide ingestion and identify factors associated with severe outcomes (death, intubation, or sustained hypotension requiring inotrope therapy).

MATERIALS AND METHODS: This multicenter retrospective study included patients who visited the emergency departments of six teaching hospitals due to acute avermectin pesticide ingestion between January 2012 and May 2020. Patients who reported ingestion of any other pesticides, drugs, or substances were excluded.

RESULTS: In total, 64 patients (median age, 72 years) were included: 60 had ingested emamectin pesticides, and 4 had ingested abamectin. Almost all (98%) were cases of self-harm. The most common presentation was drowsiness (47%), with a median Glasgow Coma Scale (GCS) score of 14, followed by shortness of breath (SOB)/dyspnea (33%) and nausea/vomiting (22%). Concurrent methanol exposure (via the solvent) was confirmed or suspected in five patients. Seventeen patients (27%) were intubated. Three patients who developed respiratory failure were not intubated because of a "do-not-resuscitate" (DNR) order. Four patients developed sustained hypotension requiring inotrope therapy. Fifty patients (78%) were admitted, of whom 27 (42%) required intensive care unit (ICU) admission. Four patients died, three of whom had a DNR order. Based on our definition, 20 patients (31%) had severe outcomes. A multivariate logistic regression model showed that a GCS score < 13 (OR 68.1, 95% CI 3.8-999) and the presence of SOB/dyspnea (OR 50.2, 95% CI 3.0-849.9) were associated with severe outcomes.

CONCLUSIONS: Most patients who intentionally ingested avermectin pesticides required inpatient treatment. Forty-two percent needed ICU care and 31% had severe outcomes. A GCS score < 13 and SOB/dyspnea were independently associated with severe outcomes.

来源:Clin Toxicol (Phila),查看原文。版权归原作者所有。

参考来源

  1. Wu YK, Chang CH, Yu JH, et al. Intentional avermectin pesticide ingestion: a retrospective multicenter study. Clin Toxicol (Phila). 2022. PMID: 35916769. doi:10.1080/15563650.2022.2104729

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。